After reviewing six rare cases of blood clots after 7 million doses, current data indicates the vaccine is safe.
After reviewing six rare cases of blood clots after 7 million doses, current data indicates the vaccine is safe.
The FDA allows emergency use in response to positive trials, but more research is needed.